PAHC

+ Watchlist + Portfolio

Phibro Animal Health Corp.

Regulated industry Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $35.87
52-Week Range: $28.25 – $60.08
Market Cap: $1.51B
P/E (TTM): 15.33
EPS (TTM): 2.43
Dividend Yield: 1.29%

Advanced Metrics

Price/Book: 3.92
PEG Ratio: 1.68
Return on Equity: 29.72%
Return on Assets: 8.48%
Gross Margin: 33.33%
Operating Margin: 10.64%
Profit Margin: 6.57%
Current Ratio: 2.96
Debt/Equity: 2.06
Total Debt: $795.65M
Free Cash Flow: $-19.30M
Revenue Growth: 4.80%
Earnings Growth: 24.60%
Enterprise Value: $2.22B

PAHC Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$942.26M	$977.89M	$1.02B	$1.30B	$1.52B
Cost of Revenue	$656.86M	$679.65M	$704.59M	$896.27M	$1.01B
Gross Profit	$285.40M	$298.24M	$313.09M	$399.94M	$512.51M
Selling, General & Admin	$206.41M	$226.39M	$259.78M	$289.48M	$318.12M
Operating Expenses	$206.41M	$226.39M	$259.78M	$289.48M	$318.12M
Operating Income	$78.99M	$71.85M	$53.31M	$110.47M	$194.40M
EBITDA	$117.13M	$106.03M	$69.06M	$146.85M	$232.96M
Pretax Income	$72.33M	$54.07M	$10.92M	$67.99M	$137.35M
Income Tax	$23.15M	$21.46M	$8.50M	$19.73M	$37.63M
Net Income	$49.17M	$32.61M	$2.42M	$48.26M	$99.72M
Diluted EPS	1.21	0.81	0.06	1.19	2.43
Diluted Shares	40.50M	40.50M	40.52M	40.68M	40.96M

PAHC Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025	FY2026
Cash & Equivalents	$74.25M	$41.28M	$70.61M	$68.04M	$61.42M
Receivables	$166.54M	$163.48M	$169.45M	$227.98M	$238.79M
Inventory	$259.16M	$277.57M	$265.91M	$444.43M	$534.88M
Current Assets	$566.23M	$585.72M	$601.00M	$810.61M	$935.51M
Total Assets	$931.70M	$971.40M	$982.18M	$1.36B	$1.50B
Current Liabilities	$190.83M	$176.00M	$204.15M	$293.47M	$316.47M
Long-Term Debt	$417.93M	$452.54M	$458.29M	$702.43M	$707.77M
Total Debt	$470.48M	$509.97M	$525.46M	$761.55M	$788.77M
Total Liabilities	$669.26M	$688.89M	$725.54M	$1.08B	$1.12B
Retained Earnings	$247.75M	$260.91M	$243.89M	$272.70M	$352.96M
Shareholders' Equity	$262.44M	$282.51M	$256.64M	$285.68M	$385.48M
Working Capital	$375.40M	$409.72M	$396.85M	$517.13M	$619.04M
Net Debt	$358.68M	$433.56M	$417.47M	$650.65M	$671.38M

PAHC Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025	FY2026
Operating Cash Flow	$31.65M	$13.31M	$87.59M	$80.12M	$68.95M
Capital Expenditure	-$37.04M	-$51.79M	-$41.24M	-$38.29M	-$59.09M
Free Cash Flow	-$5.39M	-$38.48M	$46.36M	$41.83M	$9.87M
Depreciation & Amortisation	$32.70M	$34.01M	$36.18M	$45.60M	$51.51M
Stock-Based Compensation	$0.00	$0.00	$475.00K	$717.00K	$1.60M
Investing Cash Flow	-$22.58M	-$74.02M	-$48.19M	-$288.69M	-$71.45M
Financing Cash Flow	$16.34M	$26.99M	-$6.77M	$207.13M	-$6.56M
Dividends Paid	-$19.44M	-$19.44M	-$19.44M	-$19.45M	-$19.46M
Net Change in Cash	$25.41M	-$33.72M	$32.63M	-$1.43M	-$9.06M

PAHC Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$347.82M	$378.70M	$363.89M	$373.91M	$383.54M	$396.75M
Cost of Revenue	$243.26M	$268.69M	$244.11M	$241.25M	$257.87M	$262.35M
Gross Profit	$104.57M	$110.01M	$119.78M	$132.66M	$125.67M	$134.40M
Selling, General & Admin	$71.05M	$76.29M	$68.52M	$82.33M	$81.02M	$86.24M
Operating Expenses	$71.05M	$76.29M	$68.52M	$82.33M	$81.02M	$86.24M
Operating Income	$33.52M	$33.72M	$51.26M	$50.33M	$44.65M	$48.16M
EBITDA	$51.38M	$44.71M	$61.07M	$61.16M	$54.87M	$55.80M
Pretax Income	$29.69M	$23.85M	$36.27M	$36.42M	$32.31M	$32.34M
Income Tax	$8.81M	$6.62M	$9.74M	$8.97M	$8.29M	$10.63M
Net Income	$20.88M	$17.22M	$26.53M	$27.46M	$24.02M	$21.71M
Diluted EPS	0.51	0.42	0.65	0.67	0.59	0.53
Diluted Shares	40.70M	40.70M	40.88M	40.96M	41.04M	41.00M

PAHC Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$60.35M	$68.04M	$72.77M	$55.49M	$54.93M	$61.42M
Receivables	$197.52M	$227.98M	$217.90M	$215.87M	$221.55M	$238.79M
Inventory	$448.39M	$444.43M	$471.77M	$517.35M	$539.70M	$534.88M
Current Assets	$776.02M	$810.61M	$835.80M	$862.18M	$894.07M	$935.51M
Total Assets	$1.32B	$1.36B	$1.39B	$1.41B	$1.45B	$1.50B
Current Liabilities	$266.48M	$293.47M	$270.14M	$282.37M	$281.87M	$316.47M
Long-Term Debt	$711.16M	$702.43M	$724.52M	$710.60M	$712.68M	$707.77M
Total Debt	$770.02M	$761.55M	$785.10M	$773.17M	$787.44M	$788.77M
Total Liabilities	$1.05B	$1.08B	$1.07B	$1.07B	$1.08B	$1.12B
Retained Earnings	$260.34M	$272.70M	$294.36M	$316.96M	$336.12M	$352.96M
Shareholders' Equity	$265.99M	$285.68M	$311.68M	$332.36M	$361.83M	$385.48M
Working Capital	$509.54M	$517.13M	$565.66M	$579.82M	$612.20M	$619.04M
Net Debt	$667.05M	$650.65M	$670.19M	$675.75M	$680.59M	$671.38M

PAHC Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$43.15M	$21.27M	$9.30M	$19.35M	$16.21M	$24.09M
Capital Expenditure	-$7.75M	-$13.14M	-$13.81M	-$11.10M	-$15.32M	-$18.87M
Free Cash Flow	$35.41M	$8.13M	-$4.50M	$8.26M	$890.00K	$5.22M
Depreciation & Amortisation	$12.62M	$12.41M	$12.83M	$12.89M	$12.45M	$13.35M
Stock-Based Compensation	$179.00K	$179.00K	$339.00K	$434.00K	$411.00K	$413.00K
Investing Cash Flow	-$18.25M	-$7.03M	-$21.01M	-$17.18M	-$16.81M	-$16.45M
Financing Cash Flow	-$32.22M	-$7.77M	$16.34M	-$18.98M	-$2.30M	-$1.61M
Dividends Paid	-$4.87M	-$4.86M	-$4.86M	-$4.86M	-$4.87M	-$4.87M
Net Change in Cash	-$7.32M	$6.47M	$4.62M	-$16.81M	-$2.90M	$6.03M

Market Snapshot

About

Phibro Animal Health develops, manufactures, and markets animal health products including vaccines, antibiotics, nutritional supplements, and mineral nutrition ingredients. The company serves poultry, swine, dairy, and beef producers globally. Its products help improve animal health, nutrition, and production efficiency in livestock operations.